Carroll Financial Associates’s PDL BioPharma, Inc. PDLI Stock Holding History

Carroll Financial Associates’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-19	Closed	–	–	1830
2019 Q2	$0	Buy	+19	New	+$62	﹤0.01%	1802
2015 Q4	–	Sell	-737	Closed	-$3K	–	1230
2015 Q3	$3K	Buy	737 +20	+3%	+$115	﹤0.01%	953
2015 Q2	$5K	Buy	717 +17	+2%	+$114	﹤0.01%	875
2015 Q1	$5K	Hold	700	–	–	﹤0.01%	647
2014 Q4	$5K	Hold	700	–	–	﹤0.01%	589
2014 Q3	$5K	Hold	700	–	–	﹤0.01%	677
2014 Q2	$7K	Hold	700	–	–	﹤0.01%	667
2014 Q1	$6K	Hold	700	–	–	﹤0.01%	639
2013 Q4	$5K	Buy	+700	New	+$5.9K	﹤0.01%	623

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return